Pasar al contenido principal

DESCIFRANDO EL PAPEL DE LOS GLICANOS EN LAS INFECCIONES DE VIRUS MEDIANTE RESONANCIA MAGNETICA NUCLEAR

PID2023-151109OB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2023
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD COMPLUTENSE DE MADRID

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

From diarylsulfides to diarylamines: new Ebola virus entry inhibitors with improved metabolic stability

  • Morales-Tenorio, Marcos
  • Lasala, Fátima
  • García-Rubia, Alfonso
  • Aledavood, Elnaz
  • Heung, Michelle
  • Olal, Catherine
  • Escudero-Pérez, Beatriz
  • Oquist, Paola
  • Canales, Ángeles
  • Alonso Martí, Covadonga
  • Martínez Gil, Ana
  • Muñoz-Fontela, César
  • Delgado, Rafael
  • Gil, Carmen
15 p.-7 fig.-4 tab.-1 graph. abst., The persistence of current outbreaks of Ebola virus (EBOV) disease and challenges in the production and administration of approved vaccines and treatments highlight the continuous exploration of new therapeutic alternatives. In this context, this work focuses on optimizing diarylsulfide hits previously identified as EBOV entry inhibitors. Structural modifications resulted in diarylamine derivatives, with confirmed antiviral activity against replicative EBOV and significantly improved metabolic stability compared to diarylsulfides. Using different techniques, the EBOV glycoprotein (EBOV-GP) was identified as the target of these compounds. Residue Y517GP2 is critical for biological activity, while T519GP2, E100GP1, and D522GP2 also contribute to ligand binding. Furthermore, the binding of the derivatives to EBOV-GP has been shown to destabilize the complex with the virus receptor NPC1. In short, a new family of diarylsulfides and diarylamines with antiviral activity against EBOV has been developed, and their mechanism of action has been deciphered, paving the way for future pharmaceutical development., The project leading to these results has received funding from “la Caixa” Foundation under the project code LCF/PR/HR19/52160012. This research was partially supported through ERA-NET-2021-862605 and cofounded by MICIU/AEI/10.13039/501100011033 and FEDER/UE (Grants PCI2021-121939 (C.A.), PID2021-122825OB (C.A.), PID2023-151109OB-I00 (A.C.) and PID2021-122223OB-I00 (C.G.)), Instituto de Salud Carlos III (CIBERINFEC, CIBERNED and FIS PI2100989), and the European Commission Project e-FabRIC: ID: 101137157, HORIZON-HLTH-2023-DISEASE-03-04 and Project Ebola PREP-TBOX, ID 101145709, and HORIZON-JU-GH-EDCTP3-2023-01 to RD. This research work was also funded by the European Commission–NextGenerationEU (Regulation EU 2020/2094), through CSIC’s Global Health Platform (PTI+ Salud Global). M.M.-T. holds a predoctoral FPU grant (FPU18/03493) from MICINN., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Structural Insights Into Man9 Recognition by the HIV Antibody 2G12 Revealed by Paramagnetic NMR

  • Silva-Díaz, Adrián
  • Oquist-Phillips, Paola
  • Cruz, Noelia de la
  • Lera-Lasso, Inés
  • Castañar, Laura
  • Rojo, Francisco Javier
  • Ramos-Soriano, Javier
  • Canales, Ángeles
Viral proteins contain “glycoepitopes” that can be targeted by antibodies. A prominent example is HIV gp120 glycoprotein, which contains a dense cluster of oligomannoside glycans recognized by the broadly neutralizing 2G12 antibody. 3D structures of 2G12 complexed with oligomannosides of diverse sizes have been determined using X-ray crystallography and cryo-electron microscopy, and different glycan binding epitopes have been proposed, with either the D1 arm or the D3 arm of the glycans establishing the main interactions with the antibody. In this work, we have synthesized a Man9 derivative bearing a lanthanide binding tag to perform detailed characterization of the glycan binding epitope in solution using NMR under paramagnetic conditions. This approach allows studying the Man9 structure, overcoming the signal overlapping problems found in standard NMR experiments. STD NMR analysis revealed a clear preference for the D1 arm in 2G12 antibody recognition, while the D2 and D3 branches also contributed to binding, albeit with weaker STD effects. This relevant information is fundamental for the design of immunogens to elicit 2G12-like antibodies as vaccine components, since recent studies have found that these “glycoepitopes” are also present in other viruses such as SARS-CoV-2 and certain H3N2 influenza strains. © 2026 The Author(s). Advanced Science published by Wiley-VCH GmbH., This research was funded by a grant from MICIU/AEI/10.13039/501100011033 (PID2023-151490NB-I00, PID2023-151109OB-I00) and “ERDF A way of making Europe”. AS-D and PO-P acknowledge the support of FPI scholarships (PRE2018-083270 and PRE2020-092201, respectively) financed by MICIU/AEI/10.13039/501100011033 and by “ESF Investing in your future”. We also acknowledge Prof. Javier Pérez Castells' group at the Department of Chemistry and Biochemistry, Facultad de Farmacia, Universidad San Pablo-CEU, for kindly providing us with compound 19 for the synthesis of the LBT-tagged glycan and the NMR facility of Complutense University of Madrid., Peer reviewed